Literature DB >> 15907399

Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications.

Diego F Dávila1, Tulio J Núñez, Rodolfo Odreman, Carmen A Mazzei de Dávila.   

Abstract

Patients with chronic congestive heart failure have a sequential and incessant activation of those neurohormonal systems, which control body fluids, cardiac output and systemic blood pressure. Neurohormonal activation is initially selective and regional. Generalized activation is a late event in the natural history of congestive heart failure. Although the ultimate stimulus responsible for the activation of these neurohormonal systems is unknown, a decreased cardiac output and diminished effective blood volume have been proposed as the responsible mechanisms. However, extensive clinical and experimental research suggest that cardiac remodeling and loading of low-pressure cardiac receptors with sympathetic afferents could be the triggering events followed by unloading of high-pressure carotid receptors by decreased cardiac output and diminished effective blood volume.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15907399     DOI: 10.1016/j.ijcard.2004.08.023

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

1.  Suppression of cerebral hemodynamics is associated with reduced functional capacity in patients with heart failure.

Authors:  Tieh-Cheng Fu; Chao-Hung Wang; Chih-Chin Hsu; Wen-Jin Cherng; Shu-Chun Huang; Jong-Shyan Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-28       Impact factor: 4.733

Review 2.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

3.  Physical and psychological symptom profiling and event-free survival in adults with moderate to advanced heart failure.

Authors:  Christopher S Lee; Jill M Gelow; Quin E Denfeld; James O Mudd; Donna Burgess; Jennifer K Green; Shirin O Hiatt; Corrine Y Jurgens
Journal:  J Cardiovasc Nurs       Date:  2014-07       Impact factor: 2.083

Review 4.  Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets.

Authors:  Jianglong Hou; Y James Kang
Journal:  Pharmacol Ther       Date:  2012-06-29       Impact factor: 12.310

Review 5.  The influence of heart failure self-care on health outcomes: hypothetical cardioprotective mechanisms.

Authors:  Christopher S Lee; Nancy C Tkacs; Barbara Riegel
Journal:  J Cardiovasc Nurs       Date:  2009 May-Jun       Impact factor: 2.083

6.  Direct inotropic effects of exogenous and endogenous urotensin-II: divergent actions in failing and nonfailing human myocardium.

Authors:  Michael P Quaile; Hajime Kubo; Carie L Kimbrough; Stephen A Douglas; Kenneth B Margulies
Journal:  Circ Heart Fail       Date:  2009-01       Impact factor: 8.790

7.  Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure.

Authors:  Wayne L Miller; Karen A Hartman; Diane E Grill; Joachim Struck; Andreas Bergmann; Allan S Jaffe
Journal:  Heart       Date:  2011-12-22       Impact factor: 5.994

8.  Inhibition of autoimmune Chagas-like heart disease by bone marrow transplantation.

Authors:  Maria C Guimaro; Rozeneide M Alves; Ester Rose; Alessandro O Sousa; Ana de Cássia Rosa; Mariana M Hecht; Marcelo V Sousa; Rafael R Andrade; Tamires Vital; Jiří Plachy; Nadjar Nitz; Jiří Hejnar; Clever C Gomes; Antonio R L Teixeira
Journal:  PLoS Negl Trop Dis       Date:  2014-12-18

9.  Improving Accuracy of Heart Failure Detection Using Data Refinement.

Authors:  Jinle Xiong; Xueyu Liang; Lina Zhao; Benny Lo; Jianqing Li; Chengyu Liu
Journal:  Entropy (Basel)       Date:  2020-05-02       Impact factor: 2.524

10.  A retrospective study on the short-term effect of high-dose spironolactone (80 mg/d) on chronic congestive heart failure.

Authors:  Pan Tao; Tu Zhitao; Liu Jiming
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.